Contraindications to tissue plasminogen activator thrombolysis for acute lower extremity ischemia.
Nikita SinghTyler SantosAli Basil AliHason KhanPavel KibrikJason StorchHalbert BaiMark AwadRonak PatelMichael HuberEnrico AscherNatalie MarksAnil HingoraniPublished in: Vascular (2024)
In light of our study results and advancements in endovascular therapies, we can now safely and efficiently treat patients who were previously considered contraindicated for such treatments. It is essential to individualize treatments and carefully balance the risks and benefits of endovascular versus open surgical revascularization for these patients. Additionally, we believe that the nearly 30-year-old guidelines for endovascular therapies need to be revisited and updated to align with modern technology.
Keyphrases
- aortic dissection
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- pulmonary embolism
- liver failure
- peritoneal dialysis
- prognostic factors
- percutaneous coronary intervention
- patient reported outcomes
- risk assessment
- human health
- coronary artery disease
- intensive care unit
- drug induced
- acute respiratory distress syndrome
- atrial fibrillation